3/21
07:14 pm
rlmd
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop [Seeking Alpha]
Low
Report
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop [Seeking Alpha]
3/20
10:33 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/19
04:19 pm
rlmd
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
High
Report
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
3/19
04:15 pm
rlmd
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
High
Report
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
3/12
07:30 am
rlmd
Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024
Medium
Report
Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024
3/5
07:44 am
rlmd
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
Low
Report
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
3/5
07:30 am
rlmd
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Low
Report
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
3/4
05:53 am
rlmd
Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth? [Yahoo! Finance]
Medium
Report
Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth? [Yahoo! Finance]
2/1
03:13 pm
rlmd
Relmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 Shares [Yahoo! Finance]
Low
Report
Relmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 Shares [Yahoo! Finance]
2/1
05:18 am
rlmd
Relmada Therapeutics CEO & Director Acquires 69% More Stock [Yahoo! Finance]
Medium
Report
Relmada Therapeutics CEO & Director Acquires 69% More Stock [Yahoo! Finance]